APA (7th ed.) Citation

Shahriari, M., Harrison, R. W., Burge, R., Lin, C., Malatestinic, W. N., Goldblum, O. M., . . . Murage, M. J. (2022). Disease response and patient-reported outcomes among initiators of ixekizumab. Journal of Dermatological Treatment, 33(3), 1538. https://doi.org/10.1080/09546634.2020.1853023

Chicago Style (17th ed.) Citation

Shahriari, Mona, et al. "Disease Response and Patient-reported Outcomes Among Initiators of Ixekizumab." Journal of Dermatological Treatment 33, no. 3 (2022): 1538. https://doi.org/10.1080/09546634.2020.1853023.

MLA (9th ed.) Citation

Shahriari, Mona, et al. "Disease Response and Patient-reported Outcomes Among Initiators of Ixekizumab." Journal of Dermatological Treatment, vol. 33, no. 3, 2022, p. 1538, https://doi.org/10.1080/09546634.2020.1853023.